Drug Trial Radar · NCT06045221
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,698
Actual
Start
Sep 22, 2023
Primary completion
Aug 22, 2025
Study completion Aug 22, 2025
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 21, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes and inadequate glycemic control with metformin.The study will last around 61 weeks.
Conditions
- Type 2 Diabetes
Interventions
OrforglipronDrug
Administered orally
SemaglutideDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Hemoglobin A1c (HbA1c) [Non-inferiority of 36 mg Orforglipron Versus 14 mg Semaglutide and 12 mg Orforglipron Versus 7 mg Semaglutide]Time frame: Baseline, Week 52
Locations
131 sites in 6 countries. Site status is shown where the registry gives one.
Absolute Clinical Research
Phoenix, Arizona
San Fernando Valley Health Institute
Canoga Park, California
Neighborhood Healthcare Institute of Health
Escondido, California
Velocity Clinical Research, Gardena
Gardena, California
Biopharma Informatic, LLC
Los Angeles, California
Velocity Clinical Research, Westlake
Los Angeles, California
Infinity Clinical Research - Norco
Norco, California
Valley Clinical Trials, Inc.
Northridge, California
Norcal Endocrinology & Internal Medicine
San Ramon, California
Encompass Clinical Research
Spring Valley, California
University Clinical Investigators, Inc.
Tustin, California
New West Physicians Clinical Research
Golden, Colorado
Connecticut Clinical Research - Cromwell
Cromwell, Connecticut
Clinical Research of West Florida, Inc. (Clearwater)
Clearwater, Florida
South Florida Clinical Research Institute
Margate, Florida
Miami Dade Medical Research Institute, LLC
Miami, Florida
West Orange Endocrinology
Ocoee, Florida
Latin Clinical Trial Center Florida
Tamarac, Florida
Clinical Research of West Florida
Tampa, Florida
Metabolic Research Institute, Inc.
West Palm Beach, Florida
Balanced Life Health Care Solutions/SKYCRNG
Lawrenceville, Georgia
Clinical Research Atlanta
Stockbridge, Georgia
North Georgia Clinical Research
Woodstock, Georgia
Northwest Clinical Trials
Boise, Idaho
Family First Medical Center
Idaho Falls, Idaho
American Health Network of Indiana, LLC - Greenfield
Greenfield, Indiana
Velocity Clinical Research, Valparaiso
Valparaiso, Indiana
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas
Tekton Research, Inc
Wichita, Kansas
DelRicht Research
New Orleans, Louisiana
Joslin Diabetes Center
Boston, Massachusetts
Revival Research Institute, LLC
Dearborn, Michigan
SKY Integrative Medical Center/SKYCRNG
Ridgeland, Mississippi
Kansas City Research Institute
Kansas City, Missouri
Logan Health Research
Kalispell, Montana
Wr-Crcn, Llc
Las Vegas, Nevada
Premier Research
Trenton, New Jersey
Albany Medical College, Division of Community Endocrinology
Albany, New York
Ellipsis Research Group - Brooklyn - 7th Street
Brooklyn, New York
Great Lakes Medical Research, LLC
Westfield, New York
Showing 40 of 131 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.